Correction: Urotensin II induces interleukin 8 expression in human umbilical vein endothelial cells (PLoS ONE (2014) 9, 2 (e90278) DOI: 10.1371/journal.pone.0090278);Urotensin II induces interleukin 8 expression in human umbilical vein endothelial cells

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Lee, Chung Yi ^a   Tsai, Yi Tin ^a   Loh, Shih Hurng ^b   Liu, Ju Chi ^c   Chen, Tso Hsiao ^c,d   Chao, Hung Hsing ^c,e   Cheng, Tzu Hurng ^f   Chen, Jin Jer ^g,h  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

^h INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSCRIPTION FACTOR AP 1; UROTENSIN II;

ARTICLE; BINDING SITE; CELL ACTIVITY; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; MUTATIONAL ANALYSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TISSUE DISTRIBUTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

CELL PROLIFERATION; CELLS, CULTURED; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-8; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; UROTENSINS;

EID: 84896786938     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106275     Document Type: Erratum

References (28)

1. Vita JA (2011) Endothelial function. Circulation 124: e906-912.
2. Ross B, McKendy K, Giaid A (2010) Role of urotensin II in health and disease. Am J Physiol Regul Integr Comp Physiol 298: R1156-1172.
3. Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, et al. (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci U S A 95: 15803-15808. (Pubitemid 29018781)
4. Nothacker HP, Wang Z, McNeill AM, Saito Y, Merten S, et al. (1999) Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1: 383-385. (Pubitemid 129493582)
5. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, et al. (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401: 282-286.
6. Shi L, Ding W, Li D, Wang Z, Jiang H, et al. (2006) Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells. Atherosclerosis 188: 260-264. (Pubitemid 44313921)
7. Guidolin D, Albertin G, Ribatti D (2010) Urotensin-II as an angiogenic factor. Peptides 31: 1219-1224.
8. Guidolin D, Albertin G, Oselladore B, Sorato E, Rebuffat P, et al. (2010) The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways. Regul Pept 162: 26-32.
9. Waugh DJ, Wilson C (2008) The interleukin-8 pathway in cancer. Clin Cancer Res 14: 6735-6741.
10. Yang DF, Huang H, Guan S, Zhu HF, Zhang CC, et al. (2011) Interleukin(IL)-4 promotion of CXCL-8 gene transcription is mediated by ERK1/2 pathway in human pulmonary artery endothelial cells. Mol Immunol 48: 1784-1792.
11. Meissner M, Hrgovic I, Doll M, Naidenow J, Reichenbach G, et al. (2010) Peroxisome proliferator-activated receptor {delta} activators induce IL-8 expression in nonstimulated endothelial cells in a transcriptional and posttranscriptional manner. J Biol Chem 285: 33797-33804.
12. Tsai CS, Loh SH, Liu JC, Lin JW, Chen YL, et al. (2009) Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells. Atherosclerosis 206: 86-94.
13. Dong X, Ye X, Song N, Zhao J, Di B, et al. (2013) Urotensin II promotes the production of LTC4 in rat aortic adventitial fibroblasts through NF-kappaB-5-LO pathway by p38 MAPK and ERK activations. Heart Vessels 28: 514-523.
14. Xu S, Wen H, Jiang H (2012) Urotensin II promotes the proliferation of endothelial progenitor cells through p38 and p44/42 MAPK activation. Mol Med Rep 6: 197-200.
15. Hong HJ, Hsu FL, Tsai SC, Lin CH, Liu JC, et al. (2011) Tanshinone IIA Attenuates Cyclic Strain-Induced Endothelin-1 Expression in Human Umbilical Vein Endothelial Cells. Clin Exp Pharmacol Physiol.
16. Hsu YH, Chen YC, Chen TH, Sue YM, Cheng TH, et al. (2012) Far-infrared therapy induces the nuclear translocation of PLZF which inhibits VEGF-induced proliferation in human umbilical vein endothelial cells. PLoS One 7: e30674.
17. Yao PL, Lin YC, Wang CH, Huang YC, Liao WY, et al. (2005) Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cells. Am J Respir Cell Mol Biol 32: 540-547. (Pubitemid 40770132)
18. Lee CY, Sher HF, Chen HW, Liu CC, Chen CH, et al. (2008) Anticancer effects of tanshinone I in human non-small cell lung cancer. Mol Cancer Ther 7: 3527-3538.
19. Cheng CM, Hong HJ, Liu JC, Shih NL, Juan SH, et al. (2003) Crucial role of extracellular signal-regulated kinase pathway in reactive oxygen species-mediated endothelin-1 gene expression induced by endothelin-1 in rat cardiac fibroblasts. Mol Pharmacol 63: 1002-1011.
20. Chen YL, Liu JC, Loh SH, Chen CH, Hong CY, et al. (2008) Involvement of reactive oxygen species in urotensin II-induced proliferation of cardiac fibroblasts. Eur J Pharmacol 593: 24-29.
21. Liu JC, Chen CH, Chen JJ, Cheng TH (2009) Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor. Mol Pharmacol 76: 1186-1195.
22. Dai HY, Kang WQ, Wang X, Yu XJ, Li ZH, et al. (2007) The involvement of transforming growth factor-beta1 secretion in urotensin II-induced collagen synthesis in neonatal cardiac fibroblasts. Regul Pept 140: 88-93.
23. Tian L, Li C, Qi J, Fu P, Yu X, et al. (2008) Diabetes-induced upregulation of urotensin II and its receptor plays an important role in TGF-beta1-mediated renal fibrosis and dysfunction. Am J Physiol Endocrinol Metab 295: E1234-1242.
24. Mukaida N, Mahe Y, Matsushima K (1990) Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem 265: 21128-21133. (Pubitemid 120014130)
25. Cheng M, Wu J, Li Y, Nie Y, Chen H (2008) Activation of MAPK participates in low shear stress-induced IL-8 gene expression in endothelial cells. Clin Biomech (Bristol, Avon) 23 Suppl 1: S96-S103.
26. Albertin G, Guidolin D, Sorato E, Oselladore B, Tortorella C, et al. (2011) Urotensin-II-stimulated expression of pro-angiogenic factors in human vascular endothelial cells. Regul Pept 172: 16-22.
27. Song N, Ding W, Chu S, Zhao J, Dong X, et al. (2012) Urotensin II stimulates vascular endothelial growth factor secretion from adventitial fibroblasts in synergy with angiotensin II. Circ J 76: 1267-1273.
28. Albertin G, Guidolin D, Sorato E, Spinazzi R, Mascarin A, et al. (2009) Pro-angiogenic activity of Urotensin-II on different human vascular endothelial cell populations. Regul Pept 157: 64-71.